# Improving Efficacity of Sleeve Gastrectomy With Naltrexone/Bupropion Extended-release Tablet

> **NCT06620562** · PHASE4 · RECRUITING · sponsor: **Laval University** · enrollment: 108 (estimated)

## Conditions studied

- Obesity; Drug
- Obesity, Morbid

## Interventions

- **DRUG:** Naltrexone/Bupropion
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06620562
- **Lead sponsor:** Laval University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-04
- **Primary completion:** 2028-06
- **Final completion:** 2028-08
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2025-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06620562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06620562, "Improving Efficacity of Sleeve Gastrectomy With Naltrexone/Bupropion Extended-release Tablet". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06620562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*